Texas cities dominate list of best places to work in tech, a startup contest is accepting applications, Amazon invests in Houston community, and more local innovation news. Getty Images

Just like Houston's temperatures, the Bayou City's innovation news is heating up for the summer. From a new startup competition and a big donation from Amazon to Texas cities dominating a list of best places to work in technology, here's a roundup of innovation news happening in town.

Study finds greater Houston area ranks as best place to work in tech

Four Texas metros appear on the ranking. Chart via SmartAsset

A new study from SmartAsset identified the best places to work in technology, and Houston ranked at No. 15. The researchers looked into the country's top 50 populated areas across five metrics: percentage of workers employed in tech, average salary for tech workers, ratio of average tech salary to average salary across all fields, percentage of currently listed bachelor's jobs that are in tech and cost of living.

Texas was well represented on the list, and three Lone Star State metroplexes landed on the list ahead of Houston. Dallas-Fort Worth-Arlington tied for the No. 3 position with Raleigh, North Carolina. Meanwhile, central Texas' Austin-Round Rock and San Antonio-New Braunfels tied for No. 7.

The study found that most of these top cities reside in the south, and the northeastern part of the country ranked poorly on these metrics.

Capital Factory launches $100,000 startup competition

Calling all cognitive tech startups. Photo via austinstartups.com

Austin-based Capital Factory, which has a presence across the state, has opened applications for a $100,000 contest for tech startups. The Human Performance Investment Challenge is looking for hardware and/or software solutions that enhance physical or cognitive capabilities, according to an article the organization posted.

The challenge will conclude at Fed Supernova, a virtual event on July 15. The event is in collaboration with the Army Futures Command's Innovation Combine and xTechSearch programs. Applications are open now and close June 28.

Amazon teams up with Houston Food Bank to feed at-risk seniors

The Houston Food Bank is working with Amazon to feed senior citizens. Photo courtesy of Houston Food Bank

Last month, Amazon made a strategic donation focused on providing food to senior citizens disproportionately impacted by COVID-19. The tech giant's Amazon Flex sent drivers around town to make contactless deliveries to residents' doors, and, in just two days after launching, Amazon has delivered over 3,000 pounds of food — representing more than 2,000 meals.

"For so many of our senior citizens, the pandemic is especially troubling as they have health concerns, limited mobility and need assistance for such regular tasks as grocery shopping," says Brian Greene, president and CEO of Houston Food Bank, in a news release. "Because this population needs help, we wanted to add direct food deliveries for them, and we are so thankful to Amazon for stepping up to make this happen for our beloved senior citizens."

Amazon's efforts within the Bayou City are just one part of its commitment to deliver millions of meals across the country. In addition to the donated delivery service, Amazon has gifted a $50,000 COVID-19 response grant to the local organization to go to operational needs and food supplies.

"Communities around the world are facing the COVID-19 pandemic together, and in Houston we're proud to be doing our part to support our local community," says Bri Tye, general manager at Amazon's Fulfillment Centre in Katy, in the release. "The donation of $50,000 to the Houston Food Bank, and Amazon's Flex deliveries will go directly to helping feed seniors and families who need it most."

Houston fintech startup launches new product

HighRadius has premiered a new software product. Photo via highradius.com

Houston-based fintech startup, HighRadius, which provides software solutions and automation technology, announced its new RadiusOne A/R Suite for mid-sized businesses.

"We launched the RadiusOne B2B Network to facilitate suppliers and A/R teams to digitally connect with their buyers and A/P teams for faster processing of receivables and payments. Currently, the network has millions of active businesses," says Sashi Narahari, founder and CEO of HighRadius, in a news release. "The RadiusOne A/R Suite will provide the essential apps for A/R teams at mid-sized businesses to instantly plug their ERPs and A/R processes into this network and digitally connect with their buyers across the globe."

The new product is especially key in today's work-from-home environment in order to prevent slowdowns in accounts receivable departments.

"COVID-19 is putting a lot of working capital strain on businesses globally," Narahari says. "We are hoping to help by automating clerical A/R processes for mid-sized businesses and by reducing the friction for supplier A/R teams to digitally collaborate with their buyers and A/P teams."

The Cannon partners with minority-focused angel investment group

The Business Angel Minority Association launched at a breakfast event in March. Photo by Nijalon Dunn

The Cannon — an entrepreneurial hub — has joined forces with The Business Angel Minority Association, or baMa, to prioritize diversity within angel investing in Houston.

"Diversity plays an important role in early-stage investment decisions. The existing Business Angel associations are not diverse enough and this translates to a lack of pre-seed and seed angel investment in Minority-led startups", says Maria Maso, founder and CEO of baMa, in a news release.

The organization launched earlier this year to connect angel investors to minority-led startups. This partnership is in line with The Cannon's commitment to diversity, says the Cannon's CEO, Jon Lambert.

"baMa's mission to fill the glaring need for an early-stage investment focus on minority-led startups and/or startups targeting minority-driven markets is fundamental to The Cannon's vision to deliver every entrepreneur access to the startup resources needed to thrive," Lamber says in the release.

"For us, community is diversity – our partnership with baMa will extend and enhance the support system we are passionately growing and will provide baMa with access to our expanding community of startups and partners. We're excited to see where this partnership takes us – there is so much alignment in our desire to help the entire entrepreneurial community, we are expecting to accomplish big things together."

UH program addresses need for technology teachers

UH's teachHOUSTON program is preparing the next generation of technology educators. Photo courtesy of Chris Watts/uh.edu

With the number of jobs within technology expected to grow, the University of Houston has geared up to train the future's tech educators. UH's teachHOUSTON program, which trains STEM teachers who work in economically disadvantaged high schools within Houston, recently received $1.2 million from the National Science Foundation to continue its mission.

The funding will go toward a new program called UH-ACCESS — short for Advancing Cultural and Computational Engagement in STEM Scholars. The program, which begins this fall, will train 30 UH students from varying disciplines to teach computer science, physics and technology at the high school level.

"Our goal is to prepare a diverse group of teachers who will inspire students to become the country's next technologically advanced, highly-skilled workforce," says Paige Evans, associate director of teachHOUSTON and principal investigator on the project, in a news release.

The selected UH-ACCESS scholars will receive a $12,000 scholarship per year for two years, and they will work in the field across Houston, Alvin, Pasadena, Spring Branch, and Cy-Fair Independent School Districts.

"We are trying to find potential teachers who already exhibit a sociocultural awareness," continues Evans. "Research has shown that students do better in science, technology, engineering and math if the content is connected to their community and culture."

HCC launches tech tool for job hunters

HCC is helping job hunters across the city. VioletaStoimenova/Getty Images

Houston Community College has launched a new tool for job hunters that identifies occupations and the accelerated certificate programs within the higher educational system. JobsNowHouston.org will help Houston's unemployed gain key skills and certifications to make them a more marketable employee.

"COVID-19 has challenged us all, forcing us to rethink every facet of education and community responsiveness," says Dr. Cesar Maldonado, chancellor of Houston Community College, in a news release. "JobsNowHouston.org will connect people with the resources they need to gain the skills and knowledge necessary to compete in our new workforce and is a great example of how everyone at Houston Community College is working even harder to provide training and education to fill in- demand jobs."

According to the release, COVID-19 pushed over 1.5 million Texas residents into unemployment but — at the same time — nearly 481,000 job openings have been posted recently. HCC hopes its JobsNowHouston.org initiative can connect the dots to more easily facilitate retainings and upskilling for these unemployed.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”